Repositive Overview
- Year Founded
-
2013
- Status
-
Out of Business
- Employees
-
11
- Latest Deal Type
-
Liquidation
Repositive General Information
Description
Developer of bioinformatics tools designed to solve the problems related to accessing human genome sequencing data. The company's tools provide data discovery of relevant genomic datasets, registration of datasets, and collaboration on data projects, enabling biopharma to secure data sharing and collaborations through a privacy-preserving platform.
Contact Information
Website
www.repositive.ioCorporate Office
- Betjeman House
- 104 Hills Road
- Cambridge CB2 1LQ
- England, United Kingdom
Corporate Office
- Betjeman House
- 104 Hills Road
- Cambridge CB2 1LQ
- England, United Kingdom
Repositive Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Bankruptcy: Liquidation | 12-Nov-2021 | Completed | Bankruptcy: Liquidation | |||
| 12. Early Stage VC (Series A) | 31-Mar-2017 | Completed | Generating Revenue | |||
| 11. Accelerator/Incubator | 04-May-2016 | Completed | Startup | |||
| 10. Seed Round | 02-Feb-2016 | Completed | Startup | |||
| 9. Accelerator/Incubator | 24-Jan-2016 | Completed | Startup | |||
| 8. Accelerator/Incubator | 09-Oct-2015 | Completed | Startup | |||
| 7. Accelerator/Incubator | Completed | Startup | ||||
| 6. Grant | 30-Jul-2015 | Completed | Startup | |||
| 5. Accelerator/Incubator | 20-May-2015 | $303K | Completed | Startup | ||
| 4. Grant | 30-Mar-2015 | $150K | $303K | Completed | Startup |
Repositive Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 201 | $1.234812 | $368.6 | $368.6 | 1x | $368.6 | 2.29% | |
| Ordinary | 1,110 | $1.234812 | $222.49 | $222.49 | 1x | $222.49 | 12.63% |
Repositive Comparisons
Industry
Financing
Details
Repositive Competitors (22)
One of Repositive’s 22 competitors is Nebula Genomics, a Venture Capital-Backed company based in Garden City, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nebula Genomics | Venture Capital-Backed | Garden City, NY | ||||
| DNAnexus | Venture Capital-Backed | Mountain View, CA | ||||
| Gene By Gene | Formerly VC-backed | Houston, TX | ||||
| Partek | Corporate Backed or Acquired | Chesterfield, MO | ||||
| Golden Helix | Corporate Backed or Acquired | Bozeman, MT |
Repositive Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Repositive Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Repositive FAQs
-
When was Repositive founded?
Repositive was founded in 2013.
-
Where is Repositive headquartered?
Repositive is headquartered in Cambridge, United Kingdom.
-
What is the size of Repositive?
Repositive has 11 total employees.
-
What industry is Repositive in?
Repositive’s primary industry is Other Healthcare Technology Systems.
-
Is Repositive a private or public company?
Repositive is a Private company.
-
What is Repositive’s current revenue?
The current revenue for Repositive is .
-
How much funding has Repositive raised over time?
Repositive has raised $5.59M.
-
Who are Repositive’s competitors?
Nebula Genomics, DNAnexus, Gene By Gene, Partek, and Golden Helix are some of the 22 competitors of Repositive.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
